Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the Netherlands. It is testing infliximab (tumor necrotising factor-alpha antagonist) for depression.
In Netherlands
This study is recruiting in Taiwan. It is testing Information Technology-Assisted Horticultural Therapy Program on Heart Rate Variability, Stress, Depression and Happiness Among Older Adults Resident for depression.
In Taipei
This study is recruiting. It focuses on anxiety and currently lists participation information in France.
In Saint-Aubin-sur-ScieThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In New YorkThis study is recruiting. It focuses on depression and currently lists participation information in China.
In ShanghaiThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
In CanadaThis study is recruiting. It focuses on anxiety and currently lists participation information in Syria.
In SyriaThis study is recruiting. It focuses on anxiety and currently lists participation information in China.
In ChinaThis study is recruiting. It focuses on anxiety and currently lists participation information in Spain.
In SpainThis study is recruiting in Finland. It is testing stepped care guided self-help followed by face-to-face cognitive behavioral therapy versus standalone internet-delivered or face-to-face cognitive behavioral therapy for anxiety.
In FinlandThis study is recruiting in Finland. It is testing stepped care guided self-help followed by face-to-face cognitive behavioral therapy versus standalone internet-delivered or face-to-face cognitive behavioral therapy for depression.
In FinlandThis study is recruiting. It focuses on anxiety and currently lists participation information in Syria.
In SyriaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.